AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (687.3 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Hypermethylation of the ALOX12 and CBS promoters in osteoporosis: Potential biomarkers for early diagnosis

Shang Guoa,1, Yue Wub,1, Weekai Chiaa,1, Peichun Hsua, Hongwei Wangc, Yunliang Wangd( ), Biao Zhonga,#( )
Department of Orthopedic Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China
Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai 200025, China
The University of Chicago, Department of Medicine, Chicago, IL 60637, USA
Department of Neurology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450014, China

Peer review under responsibility of Chongqing Medical University.

1 These authors contributed equally to this work.

# Lead contact.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases
Pages 30-33

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Guo S, Wu Y, Chia W, et al. Hypermethylation of the ALOX12 and CBS promoters in osteoporosis: Potential biomarkers for early diagnosis. Genes & Diseases, 2024, 11(1): 30-33. https://doi.org/10.1016/j.gendis.2023.03.005

747

Views

9

Downloads

2

Crossref

1

Web of Science

1

Scopus

0

CSCD

Received: 08 February 2023
Published: 10 April 2023
© 2023 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).